SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
137 hedge funds and large institutions have $1.37B invested in Sage Therapeutics in 2015 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 53 increasing their positions, 41 reducing their positions, and 23 closing their positions.
Holders
137
Holders Change
+3
Holders Change %
+2.24%
% of All Funds
3.6%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
27
Increased
53
Reduced
41
Closed
23
Calls
$5.22M
Puts
$6.95M
Net Calls
-$1.73M
Net Calls Change
-$7.77M
Top Buyers
1 |
1
Lord, Abbett & Co
Jersey City,
New Jersey
|
$63.9M |
2 |
BB
2
BB Biotech
Schaffhausen,
Switzerland
|
$41.3M |
3 |
3
Millennium Management
New York
|
$30.2M |
4 |
4
Jennison Associates
New York
|
$14.9M |
5 |
5
Bank of New York Mellon
New York
|
$18.1M |